Calton & Associates, Inc. Amgen Inc Transaction History

Calton & Associates, Inc.

$250 Million
Q3 2024

A detailed history of Calton & Associates, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Calton & Associates, Inc. holds 844 shares of AMGN stock, worth $235,273. This represents 0.11% of its overall portfolio holdings.

Number of Shares

844

Previous 8,465 90.03%

Holding current value

$235,273

Previous $2.73 Million 90.06%

% of portfolio

0.11%

Previous 0.46%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 21, 2024	SELL	$309.38 - $337.38 $2.36 Million - $2.57 Million	-7,621 Reduced 90.03%	844 $271,000
Q3 2024 Oct 18, 2024	BUY	$309.38 - $337.38 $2.4 Million - $2.62 Million	7,754 Added 1090.58%	8,465 $2.73 Million
Q2 2024 Jul 19, 2024	SELL	$262.75 - $319.31 $18,392 - $22,351	-70 Reduced 8.96%	711 $222,000
Q1 2024 Apr 16, 2024	SELL	$268.87 - $324.56 $24,198 - $29,210	-90 Reduced 10.33%	781 $222,000
Q4 2023 Feb 07, 2024	BUY	$255.7 - $288.46 $222,714 - $251,248	871 New	871 $250,000
Q4 2022 Jan 18, 2023	BUY	$229.03 - $291.01 $182,994 - $232,516	799 New	799 $0
Q1 2022 Apr 12, 2022	SELL	$219.27 - $242.57 $317,941 - $351,726	-1,450 Closed	0 $0
Q4 2021 Jan 13, 2022	SELL	$198.88 - $227.6 $52,902 - $60,541	-266 Reduced 15.5%	1,450 $326,000
Q3 2021 Nov 05, 2021	BUY	$212.27 - $248.7 $65,166 - $76,350	307 Added 21.79%	1,716 $365,000
Q2 2021 Aug 11, 2021	SELL	$233.58 - $259.14 $35,037 - $38,871	-150 Reduced 9.62%	1,409 $344,000
Q1 2021 May 03, 2021	SELL	$221.91 - $258.6 $4,438 - $5,172	-20 Reduced 1.27%	1,559 $388,000
Q4 2020 Jan 25, 2021	SELL	$216.38 - $257.67 $27,263 - $32,466	-126 Reduced 7.39%	1,579 $363,000
Q3 2020 Oct 30, 2020	BUY	$234.65 - $260.95 $73,914 - $82,199	315 Added 22.66%	1,705 $433,000
Q2 2020 Aug 10, 2020	BUY	$197.81 - $242.74 $20,176 - $24,759	102 Added 7.92%	1,390 $328,000
Q1 2020 Apr 30, 2020	SELL	$182.24 - $241.7 $65,970 - $87,495	-362 Reduced 21.94%	1,288 $261,000
Q4 2019 Feb 03, 2020	SELL	$189.21 - $243.2 $32,544 - $41,830	-172 Reduced 9.44%	1,650 $398,000
Q3 2019 Nov 07, 2019	BUY	$174.11 - $208.62 $9,053 - $10,848	52 Added 2.94%	1,822 $353,000
Q2 2019 Jul 09, 2019	BUY	$166.7 - $195.41 $44,675 - $52,369	268 Added 17.84%	1,770 $326,000
Q1 2019 Apr 25, 2019	SELL	$180.87 - $203.88 $34,546 - $38,941	-191 Reduced 11.28%	1,502 $286,000
Q4 2018 Feb 11, 2019	SELL	$178.4 - $208.25 $81,707 - $95,378	-458 Reduced 21.29%	1,693 $330,000
Q3 2018 Oct 24, 2018	BUY	$185.29 - $208.89 $926 - $1,044	5 Added 0.23%	2,151 $446,000
Q2 2018 Aug 10, 2018	SELL	$166.05 - $186.51 $281,786 - $316,507	-1,697 Reduced 44.16%	2,146 $421,000
Q1 2018 Apr 17, 2018	BUY	$169.43 - $198.0 $24,736 - $28,908	146 Added 3.95%	3,843 $655,000
Q4 2017 Feb 05, 2018	BUY	$168.79 - $188.59 $624,016 - $697,217	3,697	3,697 $709,000

Others Institutions Holding AMGN

# of Institutions

3,120

Shares Held

410M

Call Options Held

7.56M

Put Options Held

7.2M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Calton & Associates, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Calton & Associates, Inc. with notifications on news.

Account

Calton & Associates, Inc. Amgen Inc Transaction History